Advertisements



Allogene Therapeutics Files for IPO

Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering......»»

Category: blogSource: 247wallstSep 14th, 2018

Precision Therapeutics files to sell 167K shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 13th, 2019

Sorrento Therapeutics files to sell 9.89M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Obalon Therapeutics files to sell 3.8M shares for Lincoln Park Capital Fund

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

TCR2 Therapeutics Files Terms For U.S. IPO

TCR2 Therapeutics Files Terms For U.S. IPO.....»»

Category: topSource: seekingalphaFeb 4th, 2019

Seelos Therapeutics files to sell 357,573 shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2019

Seelos Therapeutics files to sell 15.96M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2019

Cytori Therapeutics files $10M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2019

Menlo Therapeutics files $150M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2019

IPO Update: Anchiano Therapeutics Files For $35 Million IPO

IPO Update: Anchiano Therapeutics Files For $35 Million IPO.....»»

Category: topSource: seekingalphaFeb 1st, 2019

Allogene Therapeutics announces FDA clearance of ALLO-501 IND

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

PTC Therapeutics files to sell $200M in common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Mirati Therapeutics files to sell $75M in common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Poseida Therapeutics Files For U.S. IPO

Poseida Therapeutics Files For U.S. IPO.....»»

Category: topSource: seekingalphaJan 8th, 2019

Obalon Therapeutics files to sell 3.79M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 4th, 2019

Poseida Therapeutics files for IPO

Poseida Therapeutics has filed for an initial public offering, seeking to raise up to $11.....»»

Category: topSource: marketwatchJan 4th, 2019

Aptevo Therapeutics files to sell 6M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 2nd, 2019

TCR2 Therapeutics Files for IPO

Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering......»»

Category: blogSource: 247wallstJan 2nd, 2019

TCR2 Therapeutics files for IPO

TCR2 Therapeutics filed for an initial public offering on Friday, with plans to list on Nasdaq under the ticker symbol "TCRR". Jefferies, Leerink, BMO, Wedbush and China Renaissance are underwriters on the deal. The company said it's aiming.....»»

Category: topSource: marketwatchDec 28th, 2018

South San Francisco biotech files for what could be first Bay Area IPO of 2019

Harpoon Therapeutics Inc. on Thursday filed paperwork for what could be the first Bay Area IPO of 2019. The South San Francisco company's filing comes at the end of a year in which 19 life science companies from the region went public, with half of .....»»

Category: topSource: bizjournalsDec 28th, 2018

Harpoon Therapeutics Files for IPO

Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering......»»

Category: blogSource: 247wallstDec 28th, 2018